NasoGel Spray Recall: FDA Issues Warning Over Potential Health Risks
A recent recall issued by the FDA raises concerns about potential health risks associated with NasoGel Spray. Classified as a Class II recall, this indicates the product could potentially cause adverse medical effects.
The recall, initiated by the manufacturer on December 28, 2024, and officially posted by the FDA on February 5, 2025, affects specific lot numbers: NGS751, NGS757, and NGS762. These lots, identifiable by the UPC code 00705928045309, were sold widely, including at popular pharmacies like Walgreens, Rite Aid, and Walmart.
The FDA’s concern stems from reports of nasal spray stability failure due to bioburden, meaning the product may contain harmful microorganisms. Consumers, particularly those with compromised immune systems, could experience infections and other health complications if exposed.
This recall highlights the importance of vigilance regarding product safety. Consumers are urged to immediately discontinue use of NasoGel Spray from the affected lots. Detailed instructions on returning or safely disposing of the product are available through NeilMed, the manufacturer, by contacting them directly.
The FDA continues to monitor the situation closely and encourages consumers to stay informed through official channels.
NeilMed Recall: Expanding Scope Raises Concerns
Adding to the growing concern surrounding nasal spray recalls, NeilMed, a leading manufacturer of neti pots and sinus rinse products, issued a voluntary recall affecting numerous products distributed between January 1, 2008, and September 1, 2023.
The recall encompasses both U.S. and international markets, impacting consumers in Bahrain, Ireland, Malaysia, Mexico, and the United Kingdom.
Reports of severe health complications, including bacterial and fungal infections, neurological symptoms, and fever, have prompted this extensive recall.
NeilMed acknowledges the gravity of the situation and emphasizes its commitment to consumer safety. Consumers are advised to immediately cease using affected products and contact NeilMed for detailed instructions on disposal.
The FDA urges consumers to stay informed and follow their guidance regarding this recall.
This developing situation underscores the importance of product safety and consumer vigilance.